Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
1.93Price to Book
VS
Market
Sector
Industry
History
$ 2.31Close
$ 1.11 - $ 4.65 52-Week Range
Ticker Information
Ticker
SABSCompany Name
SAB BIOTHERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQSAB BIOTHERAPEUTICS INC - Price to Book Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
SABS - P/B Historical data
| Date | Shareholders Equity | Market Capitalization | Price to Book |
|---|---|---|---|
| 6/30/2025 | $ 12.02M | $ 23.22M | 1.93 |
| 3/31/2025 | $ 21.41M | $ 16.63M | 0.78 |
| 12/31/2024 | $ 25.97M | $ 12.63M | 0.49 |
| 9/30/2024 | $ 36.9M | $ 36.46M | 0.99 |
| 6/30/2024 | $ 46.12M | $ 25.01M | 0.54 |
| 3/31/2024 | $ 52.82M | $ 31.84M | 0.6 |
| 12/31/2023 | $ 57.3M | $ 41.88M | 0.73 |
| 9/30/2023 | $ 15.26M | $ 48.66M | 3.19 |
| 6/30/2023 | $ 19.72M | $ 41.33M | 2.1 |
| 3/31/2023 | $ 24.4M | $ 44.35M | 1.82 |
Key Performance Insights, Last 5 Years
- SAB BIOTHERAPEUTICS INC's latest trailing twelve months (TTM) P/B stands at 0.
- Over the past 5 years, SAB BIOTHERAPEUTICS INC's average P/B has been 2.68.
- The median P/B for SAB BIOTHERAPEUTICS INC during this period was 1.76
- SAB BIOTHERAPEUTICS INC reached its highest P/B over the past 5 years at 12.27.
- The lowest P/B recorded by SAB BIOTHERAPEUTICS INC in the same timeframe 0.49
SAB BIOTHERAPEUTICS INC's P/B vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/B Benchmarks
Similar metrics to P/B:
- Price to Sales - [Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
Definition of Price to Book
[Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].Market Cap / Equity
(=) P/B P/B for SAB BIOTHERAPEUTICS INC is calculated as follows: Market Cap [ $ 0 ] / Equity [ $ 24.44K ]
(=) P/B [ 0 ] SABS - Price to Book, Last 5 years
0.49
Minimum
Dec 31, 2024
12.27
Maximum
Sep 30, 2021
2.68
Average
1.76
Median
P/B Benchmark AnalysisMarket
The chart above depicts the distribution of P/B for companies in the Total Stock Market. The average P/B of the companies is 2.3 with a standard deviation of 1.81.
The following table provides additional summary stats:
P/B in the Market:
| filtered constituents | 3.36K |
|---|---|
| min | 0 |
| max | 8.04 |
| average | 2.3 |
| median | 1.63 |
| std | 1.81 |